Long‐interval T2‐weighted subtraction magnetic resonance imaging: A powerful new outcome measure in multiple sclerosis trials
Lists
Only you see this
Abstract
Compared with monthly Gd-T1w imaging, long-interval T2w-Sub MRI exhibited increased power to assess treatment efficacy, and could greatly increase the cost-effectiveness of phase 2 MS trials by limiting the number of patients, contrast injections, and MRI scans needed.
BibTeX
@article{moraal2009longinterval,
author = {Bastiaan Moraal and I.J. van den Elskamp and Dirk L. Knol and Bernard M.J. Uitdehaag and Jeroen J.G. Geurts and Hugo Vrenken and Petra J. W. Pouwels and Ronald A. van Schijndel and Dominik Meier and Charles R.G. Guttmann and Frederik Barkhof},
title = {{Long‐interval T2‐weighted subtraction magnetic resonance imaging: A powerful new outcome measure in multiple sclerosis trials}},
journal = {Annals},
year = {2009},
doi = {10.1002/ana.21958},
}Loading related content...